In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder.
about
Cancer-associated CD43 glycoforms as target of immunotherapy.A new strategy for label-free detection of lymphoma cancer cellsMurine models of B-cell lymphomas: promising tools for designing cancer therapiesInfluence of Tumor Location on the Composition of Immune Infiltrate and Its Impact on Patient Survival. Lessons from DCBCL and Animal Models.Peptide-guided targeting of GPR55 for anti-cancer therapy.Nanoparticle-based strategy for personalized B-cell lymphoma therapy.Anti-tumor activity of a B-cell receptor-targeted peptide in a novel disseminated lymphoma xenograft model.Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context.B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy.Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients.Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes.Con A conjugated to Europium(III) cryptate as a new histological tool for prostate cancer investigation using confocal microscopy.A simple, clinically relevant therapeutic vaccine shows long-term protection in an aggressive, delayed-treatment B lymphoma model.
P2860
Q35072238-4BF93F41-4861-462E-8D5D-98518F52E560Q35445641-B40CDB6F-7368-44F5-873D-2B0E5B83080EQ35779492-78FA813A-E476-4FDA-B8F4-C1A7EE9EC7AAQ35931598-BBE56259-7C58-42A9-A847-05EBB0704350Q36234465-4BDB9C16-C85C-4FC7-935D-0BECFE4AD7F2Q37426956-32F281AB-01D4-4587-B4F1-172E182BB753Q39467111-2E909606-7A23-42B5-A802-13654E0C27CEQ39656680-36AA54FF-14A7-4A67-A601-AFD84053C194Q40706746-C3FEF6D9-0376-47C1-8ABD-167224312700Q41972019-522B2D66-1D1E-4575-9DC2-7270D3CCF26FQ42377367-B1396FCF-BB2C-4D93-A2EC-224AB02E4C1AQ46904149-48698E08-83AD-42E3-8397-9A4280211717Q47357871-ABC54563-08EB-46F4-AAFA-75802772CE23
P2860
In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
In vivo targeting and growth i ...... otype-specific peptide binder.
@ast
In vivo targeting and growth i ...... otype-specific peptide binder.
@en
In vivo targeting and growth i ...... otype-specific peptide binder.
@nl
type
label
In vivo targeting and growth i ...... otype-specific peptide binder.
@ast
In vivo targeting and growth i ...... otype-specific peptide binder.
@en
In vivo targeting and growth i ...... otype-specific peptide binder.
@nl
prefLabel
In vivo targeting and growth i ...... otype-specific peptide binder.
@ast
In vivo targeting and growth i ...... otype-specific peptide binder.
@en
In vivo targeting and growth i ...... otype-specific peptide binder.
@nl
P2093
P50
P1433
P1476
In vivo targeting and growth i ...... iotype-specific peptide binder
@en
P2093
Aldo Giudice
Annamaria De Laurentiis
Antonio Pisano
Cristina Falcone
Eleonora Vecchio
Enrico Iaccino
Fabrizio Dal Piaz
Franca Maria Tuccillo
Francesca Trimboli
Giuseppe Scala
P304
P356
10.1182/BLOOD-2009-11-253617
P407
P50
P577
2010-04-02T00:00:00Z